HNF4A Polyclonal antibody

HNF4A Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG


human and More (1)





Cat no : 26245-1-AP


HNF 4 alpha, HNF4, HNF4A, HNF4a7, HNF4a8, HNF4a9, HNF4alpha, MODY, MODY1, NR2A1, NR2A21, TCF, TCF 14, TCF14, Transcription factor 14, Transcription factor HNF 4

Tested Applications

Positive WB detected inHepG2 cells

Recommended dilution

Western Blot (WB)WB : 1:2000-1:12000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Published Applications

WBSee 1 publications below

Product Information

26245-1-AP targets HNF4A in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen HNF4A fusion protein Ag24637
Full Name hepatocyte nuclear factor 4, alpha
Calculated Molecular Weight 53 kDa
Observed Molecular Weight52 kDa
GenBank Accession NumberBC137539
Gene Symbol HNF4A
Gene ID (NCBI) 3172
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

HNF4A (Hepatocyte nuclear factor 4 α) is highly conserved between humans and mice. Using conditional knockouts, epithelial HNF4A is indispensable for protecting against acute chemical-induced colitis and spontaneous colonic inflammation in aged animals (PMID:35792863). Moreover, reduced expression of HNF4A has been reported in liver fibrosis and viral vector-mediated HNF4A restoration has previously been demonstrated to reverse features of chronic liver injury. Therefore, HNF4A has been suggested as a therapeutic target for the treatment of liver fibrosis (PMID:34453962).


Product Specific Protocols
WB protocol for HNF4A antibody 26245-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



BMC Complement Med Ther

Revealing active components, action targets and molecular mechanism of Gandi capsule for treating diabetic nephropathy based on network pharmacology strategy.

Authors - Qiqiang Zhang